FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3217454076> ?p ?o ?g. }

• W3217454076 endingPage "4274" @default.
• W3217454076 startingPage "4262" @default.
• W3217454076 abstract "MicroRNAs (miRs) are endogenous, single-stranded, noncoding RNAs that are involved in various physiological processes, and the development and the progression of various types of cancer. Specifically, the role of miR-200a-3p has been implicated in various types of cancer in contributing to a diverse array of cancer types has been previously reported. The present study aimed to investigate the expression levels of miR-200a-3p in human bladder cancer, as well as its potential role in disease pathogenesis.Reverse transcription-polymerase chain reaction (RT-PCR) and Western blot were used to detect the expression of has-mir-200a-3p and tumor necrosis factor α (TNF-α) induced protein 3 (A20) in tumor tissues and cell lines. Dual-luciferase reporter assay and combination with the expression intervention of hsa-mir-200a-3p and A20 in bladder cancer cell lines to clarify the binding relationship between hsa-mir-200a-3p and A20.After the expression intervention of hsa-mir-200a-3p and A20 in bladder cancer cells, the changes of cell proliferation, cell apoptosis, cell cycle, wound-healing ability and migration ability were detected by CCK8, flow cytometry, wound-healing and Transwell methods. Xenograft transplantation model was performed subcutaneously in nude mice by implantation of J82 and T24 cells, and then the bladder cancer growth curve was calculated from mice exposed to has-mir-200a-3p minic or minic-NC.Bladder cancer tissues demonstrated significantly upregulated miR-200a-3p expression levels. Moreover, increased miR-200a-3p expression was significantly associated with distant metastasis and advanced stage. In addition, compared with the miR-control (Ctr) group, miR-200a-3p overexpression promoted bladder cancer cell proliferation, migration, invasion, cell cycle, and release of inflammatory cytokines, but inhibited cell apoptosis. Mechanistically, A20 was identified as a target gene of miR-200a-3p in bladder cancer cell lines. Moreover, compared with the miR-Ctr group, the miR-200a-3p overexpression group exhibited significantly promoted tumor growth in vivo, and A20 overexpression blocked the promoting effect of miR-200a-3p on bladder cancer.The results of the present study indicated that miR-200a-3p might serve act as an oncogene in human bladder cancer by targeting a novel the gene A20 gene; therefore, miR-200a-3p and A20 might serve could serve as novel therapeutic targets for bladder cancer." @default.
• W3217454076 created "2021-12-06" @default.
• W3217454076 creator A5001021363 @default.
• W3217454076 creator A5004467371 @default.
• W3217454076 creator A5017834988 @default.
• W3217454076 creator A5019828492 @default.
• W3217454076 creator A5040040696 @default.
• W3217454076 creator A5070398632 @default.
• W3217454076 creator A5079714140 @default.
• W3217454076 creator A5091260260 @default.
• W3217454076 date "2021-11-01" @default.
• W3217454076 modified "2023-09-25" @default.
• W3217454076 title "miR-200a-3p facilitates bladder cancer cell proliferation by targeting the A20 gene" @default.
• W3217454076 cites W1979847047 @default.
• W3217454076 cites W1990376682 @default.
• W3217454076 cites W1992141516 @default.
• W3217454076 cites W2002676749 @default.
• W3217454076 cites W2005233485 @default.
• W3217454076 cites W2056230262 @default.
• W3217454076 cites W2088601708 @default.
• W3217454076 cites W2233610963 @default.
• W3217454076 cites W2302134707 @default.
• W3217454076 cites W2405198949 @default.
• W3217454076 cites W2473162054 @default.
• W3217454076 cites W2473286866 @default.
• W3217454076 cites W2560315515 @default.
• W3217454076 cites W2594786945 @default.
• W3217454076 cites W2609244474 @default.
• W3217454076 cites W2754185129 @default.
• W3217454076 cites W2804754503 @default.
• W3217454076 cites W2849671978 @default.
• W3217454076 cites W2885746990 @default.
• W3217454076 cites W2946643421 @default.
• W3217454076 cites W2955828832 @default.
• W3217454076 cites W2979143022 @default.
• W3217454076 cites W2986840065 @default.
• W3217454076 cites W2989754487 @default.
• W3217454076 cites W3004492093 @default.
• W3217454076 cites W3042013110 @default.
• W3217454076 cites W3088879962 @default.
• W3217454076 cites W3096930927 @default.
• W3217454076 cites W3158216058 @default.
• W3217454076 doi "https://doi.org/10.21037/tau-21-941" @default.
• W3217454076 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34984191" @default.
• W3217454076 hasPublicationYear "2021" @default.
• W3217454076 type Work @default.
• W3217454076 sameAs 3217454076 @default.
• W3217454076 citedByCount "2" @default.
• W3217454076 countsByYear W32174540762022 @default.
• W3217454076 countsByYear W32174540762023 @default.
• W3217454076 crossrefType "journal-article" @default.
• W3217454076 hasAuthorship W3217454076A5001021363 @default.
• W3217454076 hasAuthorship W3217454076A5004467371 @default.
• W3217454076 hasAuthorship W3217454076A5017834988 @default.
• W3217454076 hasAuthorship W3217454076A5019828492 @default.
• W3217454076 hasAuthorship W3217454076A5040040696 @default.
• W3217454076 hasAuthorship W3217454076A5070398632 @default.
• W3217454076 hasAuthorship W3217454076A5079714140 @default.
• W3217454076 hasAuthorship W3217454076A5091260260 @default.
• W3217454076 hasBestOaLocation W32174540761 @default.
• W3217454076 hasConcept C104317684 @default.
• W3217454076 hasConcept C121608353 @default.
• W3217454076 hasConcept C127561419 @default.
• W3217454076 hasConcept C145059251 @default.
• W3217454076 hasConcept C1491633281 @default.
• W3217454076 hasConcept C203014093 @default.
• W3217454076 hasConcept C2779013556 @default.
• W3217454076 hasConcept C2780352672 @default.
• W3217454076 hasConcept C29537977 @default.
• W3217454076 hasConcept C502942594 @default.
• W3217454076 hasConcept C54355233 @default.
• W3217454076 hasConcept C553184892 @default.
• W3217454076 hasConcept C55493867 @default.
• W3217454076 hasConcept C62112901 @default.
• W3217454076 hasConcept C86803240 @default.
• W3217454076 hasConcept C96232424 @default.
• W3217454076 hasConceptScore W3217454076C104317684 @default.
• W3217454076 hasConceptScore W3217454076C121608353 @default.
• W3217454076 hasConceptScore W3217454076C127561419 @default.
• W3217454076 hasConceptScore W3217454076C145059251 @default.
• W3217454076 hasConceptScore W3217454076C1491633281 @default.
• W3217454076 hasConceptScore W3217454076C203014093 @default.
• W3217454076 hasConceptScore W3217454076C2779013556 @default.
• W3217454076 hasConceptScore W3217454076C2780352672 @default.
• W3217454076 hasConceptScore W3217454076C29537977 @default.
• W3217454076 hasConceptScore W3217454076C502942594 @default.
• W3217454076 hasConceptScore W3217454076C54355233 @default.
• W3217454076 hasConceptScore W3217454076C553184892 @default.
• W3217454076 hasConceptScore W3217454076C55493867 @default.
• W3217454076 hasConceptScore W3217454076C62112901 @default.
• W3217454076 hasConceptScore W3217454076C86803240 @default.
• W3217454076 hasConceptScore W3217454076C96232424 @default.
• W3217454076 hasIssue "11" @default.
• W3217454076 hasLocation W32174540761 @default.
• W3217454076 hasLocation W32174540762 @default.
• W3217454076 hasLocation W32174540763 @default.
• W3217454076 hasOpenAccess W3217454076 @default.
• W3217454076 hasPrimaryLocation W32174540761 @default.

• next